Recent Quotes

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-03
REV		(EXPECTED)2021-08-03

Q1 2021		Est.		Actual		Surprise
EPS		-0.090		-0.110		-0.0200
REV		2.640M		2.189M		-451.000K

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
CRIS	Curis	7.70	0.10	1.32%		704.8M

Curis Frequently Asked Questions

How do I buy Curis (CRIS) stock?

You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.

View our list of the best stock brokerages.

Who are Curis's (CRIS) competitors?

Other companies in Curis’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), KalVista Pharmaceuticals (NASDAQ:KALV), 4D Molecular Therapeutics (NASDAQ:FDMT), Chinook Therapeutics (NASDAQ:KDNY) and TCR2 Therapeutics (NASDAQ:TCRR).

What is the target price for Curis (CRIS) stock?

The latest price target for Curis (NASDAQ: CRIS) was reported by B. Riley Securities on March 25, 2021. The analyst firm set a price target for 19.00 expecting CRIS to rise to within 12 months (a possible 146.75% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for Curis (CRIS)?

The stock price for Curis (NASDAQ: CRIS) is $7.7 last updated Thu Jun 24 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Does Curis (CRIS) pay a dividend?

There are no upcoming dividends for Curis.

When is Curis (NASDAQ:CRIS) reporting earnings?

Curis’s Q2 earnings are confirmed for after-market on August 3, 2021.

Is Curis (CRIS) going to split?

There is no upcoming split for Curis.

What sector and industry does Curis (CRIS) operate in?

Curis is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.